Efficacy and Safety of add-on Dapsone Versus add-on Methotrexate in Patients With Bullous Pemphigoid

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

January 3, 2025

Study Completion Date

April 1, 2025

Conditions

Bullous Pemphigoid

Interventions

DRUG

Prednisolone

prednisolone 0.75mg/kg/day (a maximum dose of 40mg at baseline) orally

DRUG

Dapsone

Dapsone 100 mg/day

DRUG

Methotrexate

Methotrexate 15 mg weekly

Trial Locations (1)

AIIMS Bhubaneswar, Bhubaneswar

All Listed Sponsors

lead

All India Institute of Medical Sciences, Bhubaneswar

OTHER